- www.onltherapeutics.com
- 1
- 1
- 23
ONL Therapeutics is a clinical-stage biopharmaceutical company committed to helping patients see the future... ONL's lead therapeutic candidate, ONL1204, is a first-in-class small peptide Fas inhibitor designed to protect retinal cells from both..
Relevance: 10.476851